CRIS Current Research Information System

BRIGHI, NICOLE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.218
EU - Europa 1.509
AS - Asia 781
AF - Africa 100
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.211
DE - Germania 340
SG - Singapore 292
IT - Italia 272
GB - Regno Unito 271
SE - Svezia 258
CN - Cina 233
VN - Vietnam 103
IE - Irlanda 102
IN - India 95
CH - Svizzera 51
FR - Francia 42
TG - Togo 42
RU - Federazione Russa 33
BG - Bulgaria 30
CI - Costa d'Avorio 28
JO - Giordania 28
BE - Belgio 27
FI - Finlandia 19
ZA - Sudafrica 19
EE - Estonia 16
UA - Ucraina 15
ID - Indonesia 14
NG - Nigeria 9
NL - Olanda 8
GR - Grecia 5
AT - Austria 4
NI - Nicaragua 4
CA - Canada 3
CL - Cile 3
ES - Italia 3
HK - Hong Kong 3
PL - Polonia 3
RO - Romania 3
AU - Australia 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
PH - Filippine 2
PT - Portogallo 2
TR - Turchia 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
NO - Norvegia 1
PK - Pakistan 1
SC - Seychelles 1
TW - Taiwan 1
Totale 4.616
Salva come PNG Salva come JPEG
Città #
Singapore 262
Fairfield 257
Chandler 252
Southend 250
Ashburn 199
Santa Clara 124
Woodbridge 118
Houston 113
Seattle 112
Wilmington 112
Princeton 106
Dublin 98
Cambridge 84
Ann Arbor 62
Boardman 62
Bern 47
Lomé 42
Bologna 41
Krefeld 41
Berlin 35
Dong Ket 30
Sofia 30
Abidjan 28
Amman 28
Westminster 28
Beijing 23
Des Moines 21
San Diego 21
Turin 20
Brussels 17
Helsinki 17
Milan 17
New York 16
Bad Bellingen 15
Jakarta 14
Rome 14
Changsha 12
Nanjing 12
Florence 11
Padova 10
Abeokuta 9
Shenyang 9
Bühl 8
Ravenna 8
Chengdu 7
Guangzhou 7
Hangzhou 7
Jinan 7
Shanghai 7
Wuhan 7
Bremen 6
Falkenstein 6
Frankfurt am Main 6
Los Angeles 6
Montescudo 6
Munich 6
Nanchang 6
Redmond 6
Saint Petersburg 6
Tianjin 6
Torino 6
Norwalk 5
Redwood City 5
Zhaotong 5
Dingle 4
Falls Church 4
Genoa 4
Ghent 4
Haikou 4
Hebei 4
Jiaxing 4
Lanzhou 4
London 4
Managua 4
Medford 4
Naples 4
Vienna 4
Baoding 3
Cesena 3
Chicago 3
Chongqing 3
Costa Mesa 3
Dearborn 3
Fort Worth 3
Fuzhou 3
Mountain View 3
Mülheim 3
Phoenix 3
San Francisco 3
Taiyuan 3
Thessaloniki 3
Zhengzhou 3
Arezzo 2
Bari 2
Boydton 2
Bucharest 2
Cinisello Balsamo 2
Dongguan 2
Empoli 2
Gallipoli 2
Totale 3.071
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 276
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 172
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 169
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 153
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 147
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 120
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 120
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 118
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 115
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 108
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 107
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 107
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 106
Severe hypernatremia as a predictor of mortality after percutaneous endoscopic gastrostomy (PEG) placement 105
Cancer in the elderly: is it time for palliative care in geriatric oncology? 104
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 99
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 95
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 95
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 93
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 90
Chromogranin A usefulness in small non-functioning pancreatic neuroendocrine tumors surgical management 88
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 86
Palliative care training and research: the development in europe and the bologna experience. 85
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 83
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 80
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 79
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis 79
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives 78
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 78
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 77
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 77
Cross-cultural differences in hospices. A retrospective study in Italy 72
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes 72
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 71
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging 71
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE) 67
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 66
The functioning side of the pancreas: a review on insulinomas 64
Plasma androgen receptor in prostate cancer 63
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 62
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis 62
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer 58
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 53
Cutaneous Scapular Lesion in an Elderly Woman 53
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study 53
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 53
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes 47
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 46
Knife-assisted resection (KAR) for small rectal neuroendocrine neoplasia 45
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 43
New prognostic biomarkers in metastatic castration-resistant prostate cancer 43
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 41
Quality of life in patients with long-standing chronic non-pathological pancreatic hyperenzymemia 40
Routine EUS-guided tissue acquisition in patients with resectable solid pancreatic masses - Pros and cons reassessment in 2020 40
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis 35
Response 34
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 33
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 19
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis 10
Totale 4.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020611 0 0 0 0 0 87 104 146 108 83 51 32
2020/2021518 97 20 20 45 40 15 14 23 68 32 13 131
2021/2022917 41 14 35 53 83 37 50 49 53 96 275 131
2022/20231.132 85 152 52 140 89 102 35 65 224 30 67 91
2023/2024490 26 56 28 28 20 67 9 26 167 16 21 26
2024/2025811 93 191 131 101 228 67 0 0 0 0 0 0
Totale 4.805